<DOC>
	<DOCNO>NCT02408575</DOCNO>
	<brief_summary>Pilot study safety , tolerability clinical performance/randomized double-blind active-controlled pilot-study . Patients recruit patient Tinnitus Center Regensburg groupwise randomize . Control group treat hear aid without notch-filter . Patients raters blind , coworker , program hearing aid , inform group assign . A Hearing aid notch amplification filter frequency specific manner , depend individual tinnitus frequency . Through special filtering neuronal functional change auditory cortex suppose affect therapeutically .</brief_summary>
	<brief_title>Hearing Aids With `` Notched Amplification '' Treatment Chronic Tinnitus</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Chronic tinnitus ( ≥ 6 month ) Score ≥ 10 TQ12 ( Goebel und Hiller ) Mild moderate hearing loss least 20 dB maximum 70 dB 250 Hz 8 kHz Tinnitus tonal character narrow band noise ( &lt; 1 oktave bandwidth ) Tinnitus frequency ≤ 8 kHz tinnitus match Written informed consent proband If therapy psychoactive substance necessary , stable least 10 day remain constant study ( change document CRF ) No regular use ( 8 hour daily ) hear aid 3 month start study Objective Tinnitus Start tinnitus therapy 3 month start study . Missing write consent Clinically relevant serious internal , neurologic psychiatric disease Abuse drug , medicament alcohol 12 week start study Other circumstance object study inclusion accord opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>